<VariationArchive VariationID="213558" VariationName="NM_000214.3(JAG1):c.1205dup (p.Gln403fs)" VariationType="Duplication" Accession="VCV000213558" Version="7" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-03-30" DateCreated="2015-10-11" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="210328" VariationID="213558">
      <GeneList>
        <Gene Symbol="JAG1" FullName="jagged canonical Notch ligand 1" GeneID="182" HGNC_ID="HGNC:6188" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20p12.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="10637684" stop="10673999" display_start="10637684" display_stop="10673999" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="10618331" stop="10654693" display_start="10618331" display_stop="10654693" Strand="-" />
          </Location>
          <OMIM>601920</OMIM>
          <Haploinsufficiency last_evaluated="2020-10-19" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=JAG1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-10-19" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=JAG1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000214.3(JAG1):c.1205dup (p.Gln403fs)</Name>
      <CanonicalSPDI>NC_000020.11:10650275:GGGGGG:GGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>20p12.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="10650275" stop="10650276" display_start="10650275" display_stop="10650276" variantLength="1" positionVCF="10650275" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="10630923" stop="10630924" display_start="10630923" display_stop="10630924" variantLength="1" positionVCF="10630923" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <OtherNameList>
        <Name>1618insC</Name>
      </OtherNameList>
      <ProteinChange>Q403fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007496.1" sequenceAccession="NG_007496" sequenceVersion="1" change="g.28771dup">
            <Expression>NG_007496.1:g.28771dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1191t1" sequenceAccession="LRG_1191t1" change="c.1205dup">
            <Expression>LRG_1191t1:c.1205dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1191p1" sequenceAccession="LRG_1191p1" change="p.Gln403fs">
            <Expression>LRG_1191p1:p.Gln403fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1191" sequenceAccession="LRG_1191" change="g.28771dup">
            <Expression>LRG_1191:g.28771dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.10630929dup" Assembly="GRCh37">
            <Expression>NC_000020.10:g.10630929dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.10650281dup" Assembly="GRCh38">
            <Expression>NC_000020.11:g.10650281dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000214.3" sequenceAccession="NM_000214" sequenceVersion="3" change="c.1205dup" MANESelect="true">
            <Expression>NM_000214.3:c.1205dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000205.1" sequenceAccession="NP_000205" sequenceVersion="1" change="p.Gln403fs">
            <Expression>NP_000205.1:p.Gln403fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA321712" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="601920.0008" DB="OMIM" />
        <XRef Type="rs" ID="35615084" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff standardized the representation of allelic variant 601920.0008 by mapping 1618insC (based on U73936.1), reported in table 2 in the paper by Krantz et al., 1998 (PubMed 9585603) to a reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000214.3(JAG1):c.1205dup (p.Gln403fs) AND Alagille syndrome due to a JAG1 point mutation" Accession="RCV000008061" Version="9">
        <ClassifiedConditionList TraitSetID="2076">
          <ClassifiedCondition DB="MedGen" ID="C1956125">Alagille syndrome due to a JAG1 point mutation</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-10" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000214.3(JAG1):c.1205dup (p.Gln403fs) AND not provided" Accession="RCV000197265" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2014-07-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-10" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2015-10-11" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11180599</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9585603</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2076" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="142" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Alagille syndrome due to a JAG1 point mutation</ElementValue>
                <XRef ID="MONDO:0016862" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">JAG1-Related Alagille Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alagille syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HEPATIC DUCTULAR HYPOPLASIA, SYNDROMATIC</ElementValue>
                <XRef Type="MIM" ID="118450" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AHD</ElementValue>
                <XRef Type="MIM" ID="118450" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AWS</ElementValue>
                <XRef Type="MIM" ID="118450" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ALGS1</ElementValue>
                <XRef Type="MIM" ID="118450" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Alagille syndrome (ALGS) is a multisystem disorder with a wide spectrum of clinical variability; this variability is seen even among individuals from the same family. The major clinical manifestations of ALGS are bile duct paucity on liver biopsy, cholestasis, congenital cardiac defects (primarily involving the pulmonary arteries), butterfly vertebrae, ophthalmologic abnormalities (most commonly posterior embryotoxon), and characteristic facial features. Renal abnormalities, growth failure, developmental delays, splenomegaly, and vascular abnormalities may also occur.</Attribute>
                <XRef ID="NBK1273" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17251" />
                <XRef ID="17251" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301450</ID>
                <ID Source="BookShelf">NBK1273</ID>
              </Citation>
              <XRef ID="261619" DB="Orphanet" />
              <XRef ID="52" DB="Orphanet" />
              <XRef ID="C1956125" DB="MedGen" />
              <XRef ID="MONDO:0016862" DB="MONDO" />
              <XRef Type="MIM" ID="118450" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="465573" SubmissionDate="2015-09-30" DateLastUpdated="2015-10-11" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="27348" />
        <ClinVarAccession Accession="SCV000250485" DateUpdated="2015-10-11" DateCreated="2015-10-11" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-07-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1205dupC mutation in the JAG1 gene has been reported previously in association with Alagille syndrome using different nomenclature (Krantz, et al., 1998) . The duplication causes a frameshift starting with codon Glycine 403, changes this amino acid to a Threonine residue and creates a premature Stop codon at position 13 of the new reading frame, denoted p.Gln403ThrfsX13. This mutation is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay This variant was found in JAG1</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="JAG1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Q403Tfs*13</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000214.2:c.1205dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="28266" SubmissionDate="2016-12-12" DateLastUpdated="2017-01-06" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="601920.0008_ALAGILLE SYNDROME 1" title="JAG1, 1-BP INS, 1618C_ALAGILLE SYNDROME 1" />
        <ClinVarAccession Accession="SCV000028266" DateUpdated="2017-01-06" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1998-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 unrelated patients with Alagille syndrome (118450), Krantz et al. (1998) identified a 1-bp insertion at nucleotide 1618 in the JAG1 gene.</Attribute>
              <Citation>
                <ID Source="PubMed">9585603</ID>
              </Citation>
              <XRef DB="OMIM" ID="118450" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="JAG1" />
          </GeneList>
          <Name>JAG1, 1-BP INS, 1618C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 1618C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601920.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ALAGILLE SYNDROME 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1828629" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="367213|MedGen:C1956125" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000934811" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9585603</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11180599</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 213558). This premature translational stop signal has been observed in individual(s) with Alagille syndrome (PMID: 9585603). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln403Thrfs*13) in the JAG1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in JAG1 are known to be pathogenic (PMID: 11180599).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="JAG1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.10:g.10630923_10630924insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1956125" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="465573" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="28266" TraitType="Disease" MappingType="Name" MappingValue="ALAGILLE SYNDROME 1" MappingRef="Preferred">
        <MedGen CUI="C1956125" Name="Alagille syndrome due to a JAG1 point mutation" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1828629" TraitType="Disease" MappingType="XRef" MappingValue="C1956125" MappingRef="MedGen">
        <MedGen CUI="C1956125" Name="Alagille syndrome due to a JAG1 point mutation" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

